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Children's Health Articles

Chronic Arsenic Exposure and Risk of Infant Mortality in Two Areas of Chile
Claudia Hopenhayn-Rich,1 Steven R. Browning,1 Irva Hertz-Picciotto,1 Catterina Ferreccio,3 Cecilia Peralta,1 and
Herman Gibb4
1Department of Preventive Medicine and Environmental Health, University of Kentucky, Lexington, Kentucky, USA; 2Department of
Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA; 3GREDIS/Universidad Cat6lica
Pontificia, Las Condes, Santiago, Chile; 4National Center for Environmental Assessment, U.S. Environmental Protection Agency,
Washington, D.C., USA

Chronic arsenic exposure has been aociated with a range of neurologic, vascular, dermatologic,
and carcinogenic effects. However, limited research has been directed at the association of arenic
exposure and human reprodu health outcomes. The principal aim of this study was to investigate the trends in infant mortality between two geographic locations in Chile: Antofagsta,
which has a well-documented history of arsenic exposure from naturally contaminated water, and
Valparso, a comparable low-exposure city. The arsenic concentration in Antofagsta's public
drinking water supply rose substantially in 1958 with the introduction of a new water source, and
remained elevated until 1970. We used a retrospective study design to examine time and location
patterns in infant mortality between 1950 and 1996, using univariate statistics, graphical techniques, and Poisson regression analysis. Results of the study document the general declines in late
fetal and infant mortality over the study period in both locations. The data also indicate an elevation of the late fetal, neonatal, and postneonatal mortality rates for Antofagasta, relative to
Valparaiso, for specific time periods, which generally coincide with the period of highest arsenic
concentration in the ddnking water of Antofagasta Poisson regression analysis yielded an elevated and significant association between arsenic exposure and late fetal mortality [rate ratio (RR) =
1.7; 95% confidence intervl (CI), 1.-1.9], neonatal mortality (RR = 1.53; CI, 1.4-1.7), and
postneonatal mortlity (RR = 1.26; CI, 1.2-1.3) after adjustment for location and calendar time.
The findings from this investigation may support a role for arsenic exposure in increasing the risk
of late fetal and infant mortality. Key words arsenic, Chile, drinking water, infnt mortality,
neonatal death, reproductive effect, stillbirth. Environ Health Perspect 108:667-673 (2000).
[Online 6 June 20001
http:/fehpnetl. niebs. nih.govldos/2000/ 08p667-673hope nbayn-riclabract.hbtml

Arsenic is a naturally occurring element that
is present in the environment in both organic and inorganic forms. Human exposures to
the more toxic inorganic arsenic compounds
result from exposures in occupational settings, such as metal smelting and pesticide
production, as well as from medicinal treatments and environmental sources (1,4. The
use of drinking water with elevated arsenic
concentrations, primarily from natural contamination, has been the main source of
environmental exposures in populations
worldwide, including but not limited to
communities in Taiwan (3), India (4),
Bangladesh (5), Thailand (6), Mexico (7),
Chile (8), Argentina (9), China (10), and
Hungary (11). In the United States, it is
estimated that 350,000 people obtain their
drinking water from sources containing
> 50 pg/L arsenic, the current maximum
contaminant level (MCL) set by the U.S.
Environmental Protection Agency (EPA)
(12). Although higher exposures are more
common in western states, recent concerns
have also focused on other geographic
regions where private well use is common. In
areas where arsenic has been more extensively measured, levels are near the EPA MCL
(12) or the World Health Organization recommended guidance values of 10 pg/L (e.g.,

Minnesota, New Hampshire, and Michigan)
(13-15).
Chronic arsenic exposure at high doses
has neurologic, dermatologic, vascular, and
carcinogenic effects (1,2,16,17). Exposure to
arsenic from drinking water increases the
risks of skin, lung, and bladder cancers
(18-20), and also seems to be associated with
diabetes (21,22).
The possible impact of arsenic on reproductive effects has been given less attention,
but the collective evidence from human and
laboratory studies suggests the potential for
adverse effects on several reproductive end
points. Studies have reported adverse reproductive impacts among the offspring of
employees and nearby residents of a Swedish
copper smelter where arsenic exposures were
documented (23-26). Female workers gave
birth to lower weight infants than women
who resided outside the smelter area, and the
difference was greater if the mothers worked
in highly exposed jobs (25). An incremental
trend in the rates of spontaneous abortions
was observed with increasing occupational
and residential exposure (24,25). Congenital
malformations appeared to be more frequent
if the mother was employed in highly
exposed jobs during pregnancy (26).
In Bulgaria, the incidence of toxemia of
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pregnancy and the mortality from congenital
malformations were significantly higher than
the national rates in an area near a smelter
with environmental contamination from
various metals (27). A study in Texas found
an increase in the rates of stillbirths in relation to residential exposures from an arsenic

pesticide factory (28). Although arsenic
exposures were documented in all of these
studies on reproductive effects, confounding
from other metals or from other potential
risk factors could not be excluded.
Studies of populations exposed to arsenic
from drinking water have found increased
rates of spontaneous abortions and stillbirths
in Hungary (11) and Argentina (29). In the
United States, three studies reported adverse
reproductive effects, including increases in
mortality from congenital cardiovascular
anomalies (30,31) and spontaneous abortions (34. Exposed groups from these studies had arsenic levels that were quite low,
making the results difficult to interpret.
Given the methodologic limitations of
the current epidemiologic evidence, the literature on arsenic and adverse reproductive
outcomes is suggestive, but not conclusive.
However, the teratogenicity of arsenic in animals is well documented and generally consistent, showing that arsenic induces neural
tube defects as well as malformations of other
systems (33-36). The effects are dependent
on dose, route, and timing of administration
(35). Placental transfer of inorganic arsenic
occurs in both animals and humans (37-44.
A recent study in an area of Argentina with
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Materials and Methods

high arsenic in drinking water (250 )ig/L)
found a close relationship between placental
and cord blood arsenic levels, indicating considerable placental transfer of arsenic to the
developing fetus during pregnancy (43).
Several areas of northern Chile have had
a history of arsenic exposure. The surface
water that supplies most of the towns and villages in the Atacama Desert region comes
from rivers originating in the Andes mountains. Antofagasta, the largest city in this area,
with a current population of approximately
250,000 people, has had a unique pattern of
arsenic exposure that has been well described
and which warrants further epidemiologic
investigation. In 1958, because of insufficient water supply to serve the growing population and the decrease in water availability,
water from the Toconce River was introduced as the new main water source. The
river was later found to have arsenic concentrations of approximately 800 pg/L. The first
reported cases of chronic arsenic health
effects in Antofagasta appeared in 1962 (44),
and a number of publications followed
(8,20,45,46). After 12 years of high arsenic
exposure, an arsenic-removal plant was
installed in 1970 at the public water supply
company, which led to a subsequent decrease
in arsenic concentrations.
The purpose of this study was to compare the rates of stillbirth and infant mortality over time between Antofagasta, an area
with historically high water arsenic levels,
and Valparaiso, a comparison community
with low arsenic concentrations in drinking
water. We studied 47 years spanning from
1950 to 1996. This study period allows us to
examine changes that may be related to the
sharp increase in arsenic levels found in the
drinking water of Antofagasta starting in
1958 and to the subsequent decrease starting
in 1970. We also examined the general time
trends in infant mortality of these two major
Chilean cities over almost half a century.

Stdy design andpopulation. This study used
a retrospective ecologic design, incorporating

secondary vital statistics data and environmental measurement data of arsenic levels in
the public water supplies of Antofagasta and
Valparaiso. Our primary interest was to compare infant mortality rates over time between
Antofagasta, an area with historic high water
arsenic levels, and Valparaiso, a comparison
community with no historical evidence of
high arsenic water contamination. Both cities
are major Chilean ocean ports, similar in size
and other sociodemographic characteristics
(Table 1). Their locations are shown in
Figure 1.
Vital statistics data. We obtained vital
statistics data from the Instituto Nacional de
Estadisticas (INE) in Santiago, Chile, which
centralizes both local and national vital statistics and census information. Natality and
mortality data were obtained for the period
1950 to 1996 from INE annual reports. The
INE infant mortality data are classified separately as late fetal deaths (over 28 weeks of
gestation, also commonly referred to as stillbirths) and infant deaths, dichotomized into
categories of infants younger than 28 days of
age (neonatal) and those 28 days to 1 year of
age (postneonatal).
The birth and mortality data were reported by geographic locations. Since 1976, Chile
has been stratified into regions numbered
1-12 from north to south. The regions have
been further divided into provinces, and then
into comunas (equivalent to counties in the
United States). Before 1976, Chile was divided into 25 provinces, and throughout the
years, changes in both the number and jurisdiction of geographic boundaries occurred.
An in-depth reclassification of geographic
areas developed common units of analysis to
achieve compatibility across time for all
regions of Chile, using the comuna as the

smallest unit of analysis (52). The majority of
the population in the comunas of Antofagasta
and Valparai'so live in cities bearing the same
names (99 and 97%, respectively), thus making the comuna and city almost the same.
Births and deaths are reported by both
place of occurrence and place of maternal
residence. Because our interest is in the relationship between infant mortality and
arsenic exposure from drinking water (either
through maternal or infant ingestion), we
used the location of maternal residence for
coding the birth and death data.
Environmental exposure data. We
obtained the average levels of arsenic from
public water supplies for the period
1950-1996 from summarized data collected
from local water company records and the

Table 1. Demographic characteristics of Valparaiso and Antofagasta.a
Valparaiso
Antofagasta
Year
1950
1970
1982
1992
1950
1970
1982
1992
Total population of county
424,799 254,812 272,520 283,000 165,005 127,967 186,341 228,000
or provinceb

Number of persons per
household (average)
Population served by public
water supply (%)
Population with electricity (%)
Educational status (%)
Basic (grades 1-7)
Middle (grades 8-12)
High (postsecondary)
Poverty level
Indigent (%)
Poor, not indigent(%)

4.9

-

4.0

3.9

4.8

-

4.4

4.3

80.9

81.0

94.5

97.3

60.9

88.4

93.0

97.9

81.7

-

-

98.0

78.2

-

-

98.6

82.4
16.4
1.2

67.0
22.2
3.0

55.0
32.9
5.9

47.2
40.0
10.5

73.2
24.2
2.6

64.7
21.8
4.7

53.9
30.5
9.8

45.3
38.3
13.7

-

-

-

-

-

-

-

4.7
17.5

-

-

-

-

-

4.2
12.4

-, data not available in the census reports reviewed by authors.

'Data from Census reports (47-50). b1970, 1982, and 1992 data for county; 1950 data for province.
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rigure 1. Map o0 unile, incluaing stuay locations
of Antofagasta and Valparaiso. Adapted from
Maps of the Americas (51).
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regional health service (53) (Table 2). Before
1958, arsenic levels in the water of Antofagasta averaged 90 pg/L. After the introduction of the Toconce River as the main water
source, the mean arsenic levels during the
period 1958-1970 rose to approximately 860
pg/L. In 1970, the city installed an arsenicremoval plant for this water supply. Results
of subsequent measurements indicated a
decline in the arsenic levels over the next 26
years, with 1996 levels close to 50 ,ug/L.
In contrast, Valparaiso has no recorded
evidence of elevated arsenic concentrations
in the drinking water. Recent water surveys
for Valparaiso, conducted by the Chilean
National Environmental Commission
(CONAMA) (54) and by our group, show
low arsenic levels (< 5 pg/L). Data collected
from water companies from 1990 to 1994
and summarized in the CONAMA study
(54) also show that arsenic water levels in
Valparaiso were below the analytical detection
limit (20 pg/L). Although we do not have
data before 1990, there is no reason to believe
that Valparaiso had past exposures to arsenic
from drinking water. The natural high
arsenic contamination of water from geologic
sources is specific to areas in northern Chile.
Consequently, no major populations have the
history of high exposures to arsenic from
drinking water experienced by Region II,
which includes Antofagasta (20). For the purpose of this study, we assumed that Valparaiso
had low drinking water arsenic concentrations
over the time period of study.
Statistical analysis. We used univariate
statistics and graphical techniques to calculate and examine the time trends in infant
mortality for Antofagasta and Valparaiso
over the study period. We calculated annual
infant mortality rates by dividing the number of deaths by the number of live births
per location and multiplying by 1,000. For
late fetal mortality, we divided the number
of fatalities in each year by the number of
live births plus late fetal deaths to obtain the
death rate per total births. After calculating
yearly mortality rates for each group, we
noted considerable variation from year to
year, given the small number of annual
deaths at each study location. Therefore, we
grouped the rates into 4-year periods (except
for the last period, for which we only had 3
Table 2. Average drinking water arsenic levels in

Antofagasta.a
Years
1950-1957
1958-1970
1971-1979
1980-1987
1988-1 996

Concentration (pg/L)
90
860

110
70
40
aData represent an average of existing arsenic
measurements, as presented by Pedreros (53).
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of data) to improve the stability of the
mortality rates while maintaining a distinct
time period of high arsenic exposure in
Antofagasta.
For 3 years (1968-1970), the INE infant
mortality data were reported as late fetal
deaths and live-born infants who died before
the end of their first year, without subdividing the latter into neonatal and postneonatal
groups. For these 3 years, we imputed the
number of neonatal and postneonatal deaths
by linear interpolation. We calculated the
ratio of neonatal deaths to the total number
of infant deaths for each of the three previous years (1965-1967) and the three subsequent years (1971-1973). We used the slope
of the fitted line through these six data
points to estimate the proportion of neonatal
deaths for the missing years, and multiplied
it by the total number of deaths of infants
younger than 1 year of age to obtain the
neonatal deaths. We used the same method
to estimate the number of postneonatal
deaths. Rate differences were calculated
between Antofagasta and Valparalso for the
three mortality outcomes for each 4-year
period. We used rate differences to estimate
the number of excess late fetal, neonatal, and
postneonatal deaths that could be associated,
at least in part, with the increase in arsenic
exposure from drinking water in Antofagasta
over the peak exposure years.
years

Poisson regression analysis. We used
Poisson regression analysis to fit the mortality
rates (late fetal, neonatal, and postneonatal) as
a function of the estimated exposure to
arsenic by log-linear regression models while
adjusting for location and calendar time.
Predictor variables in the model included
location (Antofagasta or Valparalso), calendar
time (by 4-year intervals beginning in 1950),
and arsenic exposure, entered into the model
either as a continuous or dichotomous exposure variable. The inclusion of city in the
models enabled us to control for differences
other than arsenic that can explain variations
in infant mortality, such as socioeconomic or
health-care-related factors. For arsenic as a
continuous variable, we used available historical arsenic levels in drinking water supplies to
estimate averages for each 4-year period in
each location. For the low exposures in
Valparaiso, we assumed arsenic water levels of
5 pg/L. The dichotomous variable (present/
absent) was created to serve as an exposure
indicator only for Antofagasta during the
years of high arsenic exposure (1958-1970).
Because arsenic levels decreased after the
installation of the arsenic-removal plant in
March 1970, we only considered three higharsenic year groups: 1958-1961, 1962-1965,
and 1966-1969. For all other time periods
and locations, this indicator variable was
coded as a zero (absent). City, calendar time,

108 1 NUMBER 7 July 2000

and one of the arsenic exposure variables were
included in the Poisson regression models and
goodness-of-fit was evaluated using graphical
approaches plotting observed and expected
rates over calendar time.
We calculated adjusted rate ratios (RRs)
and the associated 95% confidence intervals
(CIs) from the parameters estimated by the
model. The calendar time period 1974-1977
served as the referent period for the model,
chosen because it was after the end of the
high arsenic period and quite close to the
mid point of the entire study time. The
analysis was performed using the PROC
GENMOD procedure provided in the SAS
software (55). The model was fit with the
Poisson distribution with the link function
as the log and the offset as the log of the
appropriate denominator (i.e., total births).
The results obtained using the arsenic exposure variable as either a continuous or as a
categorical variable were not materially different; therefore, the results are shown for
arsenic as a categorical variable.

Results
Demographic data for Valparalso and
Antofagasta representing several decades
were obtained from INE census reports
(47-50) and are presented in Table 1.
These data indicate that Antofagasta and
Valparaiso are comparable on a number of
characteristics, although these indicators
have changed over time.
Infant and late fetal mortality rates
declined markedly in Chile during the study
period of 1950-1996, as illustrated in Figure
2. This decrease is characteristic of most
Latin American countries; it follows the general trend observed in industrialized nations
and is largely due to improvements in living
conditions and health care (56). The rate of
decline up to the 1980s was the most pronounced for postneonatal mortality, with
more gradual declines evident for neonatal
and late fetal mortality.
Figures 3-5 show secular trends in late
fetal, neonatal, and postneonatal mortality
rates, respectively, by 4-year intervals, for
Antofagasta and Valparaiso. Between 1950
and 1996, Antofagasta experienced an 86%
decline in the late fetal mortality rate, an
81% decline in the neonatal mortality rate,
and a 92% decline in the postneonatal mortality rate. Similarly, the declines in infant
mortality rates for Valparaiso were 64, 77,
and 92%, respectively. It is evident that
Antofagasta experienced a more substantial
decline in the late fetal mortality rate over
this calendar period, whereas the relative
decreases in neonatal and postneonatal mortality rates were similar in both locations.
Despite the overall decline, rates for all outcomes increased in Antofagasta during the
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calendar period 1958-1961 and declined
thereafter. The increases and declines vary by
outcome, but overall they coincide with the
period of higher arsenic levels in the drinking water supply of Antofagasta. Table 3
shows the comparison of rates between the
two areas. During the period of maximum
difference in rates between the two communities (1958-1961), Antofagasta had an
excess rate of approximately 20 late fetal
deaths, 24 neonatal deaths, and 24 postneonatal deaths per 1,000 births (Table 3).
The total estimated excess of 68 deaths per
thousand births is equivalent to approximately 770 of the 1,900 combined late fetal and
infant deaths which occurred during that
time period. Subsequent to 1974, mortality
rates exhibit a more gradual decline and are
very similar between the two communities.
Results from the Poisson regression
analysis of the rates of late fetal, neonatal,
and postneonatal mortality are given in
Table 4. We observed significantly elevated
RRs for high arsenic exposure in association
100 _

with each of the three mortality outcomes,
after adjustment for location and calendar
time. The association between arsenic exposure and late fetal mortality exhibited the
strongest association (RR = 1.72; CI,
1.54-1.93), with neonatal mortality (RR =
1.53; CI, 1.40-1.66), and postneonatal
mortality (RR = 1.26; CI, 1.18-1.34) also
yielding elevated RRs, respectively. The variable for location demonstrated a significant
association with each outcome, although the
magnitude was less than that between
arsenic exposure and each outcome. The
rate ratios for the 4-year calendar groups
exhibited the predictable secular declines
over time.

lower, but still elevated, risk for neonatal and
postneonatal mortality. This association was
evident after controlling for geographic
location and calendar time in Poisson
regression models.
The mortality rates in both Antofagasta
and Valparaiso reflect the well-established
decline in late fetal, neonatal, and postneonatal mortality that occurred in Chile
over the study period (57. Improvement in
the standard of living, development of programs for maternal and infant care (prenatal,
nutritional supplementation, and health
education, among others), and the decrease
in birth rate are considered the primary factors accounting for the substantial improvement in infant mortality rates during this
period (56,58,59). The steeper decline in
postneonatal mortality supports these changing patterns of infant mortality because diarrheal infections and other childhood diseases
that are much less fatal under improved
health and living conditions are common
throughout the first year of life.

Discussion
The results of this study indicate that exposure to inorganic arsenic from public water
supplies may be associated with an increased
risk of infant mortality. Specifically, the data
suggest that arsenic exposure may represent a
greater risk for late fetal mortality with a
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Table 3. Mortality rates and rate differences for Antofagasta and Valparaiso, by 4-year periods.a

Years
1950-1953
1954-1957
1958-1961
1962-1965
1966-1969
1970-1973
1974-1977
1978-1981
1982-1985
1986-1989
1990-1993
1994-1996

ANTOF
32.2
25.9
29.3
28.6
25.2
19.4
9.1
5.3
5.4
5.4
4.3
4.5

Late fetal
VALP
RD
15.9
16.3
9.3
16.7
9.6
19.7
12.3
16.4
11.0
14.3
8.3
11.1
-1.7
10.9
5.9
-0.5
3.8
1.6
6.5
-1.0
-2.1
6.3
5.8
-1.2

Cl
15.4-17.3
15.8-17.4
18.9-20.5
15.6-17.0
13.5-14.9
10.5-11.7

(1.3-2.3)
(0.3-0.9)
1.3-1.9
(0.7-1.5)
(1 .6-2.4)

(0.9-1.7)

ANTOF
38.4
39.0
45.7
43.2
33.5
23.8
20.9
16.5
13.2
11.4
8.5
7.3

Neonatal
VALP
RD
34.7
3.7
28.3
10.7
22.1
23.6
25.2
18.0
23.2
10.3
0.7
23.1
21.3
-0.5
14.1
2.3
9.9
3.3
9.3
2.2
8.0
0.5
8.0
-0.7

Cl
3.0-4.4
9.9-11.5
22.7-24.5
17.2-18.8
9.6-11.0
0.2-1.3
(0.1-0.9)
1 .9-2.9
2.8-3.8
1.7-2.5
0.1-0.9

(0.3-1.2)

ANTOF
69.8
74.8
93.0
73.1
62.1
31.0
30.5
13.0
11.2
7.1
7.0
5.4

Postneonatal
VALP
RD
78.4
-8.6
65.5
9.2
69.3
23.7
55.4
17.6
45.8
16.3
26.9
4.0
22.2
8.4
13.5
-0.5
10.1
1.1
9.3
-2.2
6.7
0.3
6.1
-0.8

Cl
(7.8-9.4)
8.5-10.1
22.8-24.6
16.8-18.6
15.4-17.2
3.5-4.7
7.6-9.0
(0.03-1.0)
0.7-1.5

(1.8-2.6)
0.04-0.6
(0.3-1.11

Abbreviations: ANTOF, Antofagasta; VALP, Valparaiso; RD, rate difference.
&Mortality rates were calculated per 1,000 live births for neonatal and postneonatal period, and per 1,000 total births (live + late fetal) for the late fetal period.

Although both Antofagasta and Valparaiso experienced substantial improvements in their overall infant mortality rates
over the study period, the pattern of infant
mortality for these two communities was
quite different before the 1970s. Antofagasta
exhibited marked increases in late fetal,
neonatal, and postneonatal mortality in
1958-1961. As compared to Valparaiso, these
rates remained elevated until 1974-1977 for
late fetal mortality, and until 1970-1973 for
neonatal and postneonatal mortality. The
pattern of increase and subsequent decline in
Antofagasta's mortality rates show a close
temporal relationship with the rather sudden
and sharp rise in the levels of arsenic in the
city's public water supply from 1958 until
March 1970, when an arsenic-removal facility was installed, and suggest a possible role
for inorganic arsenic in the observed increase
in infant mortality.
As in the rest of the country, the decline
in mortality rates in Antofagasta during the
overall study period was likely a result of
other nonarsenic-related factors such as
improvement in health care and standard of
living, which affected all of the regions in
Chile. Moreover, starting in the 1960s,
Region II, which includes the city of Antofagasta, experienced a surge of economic
expansion, with a rate of growth and development greatly surpassing that of the rest of
the country: the increase in adjusted annual
per-capita income was greater by far in
Region II than any other region (60). This
expansion brought improvements in regional health care as well, which may explain, at
least in part, the fact that in the period
before 1958 Antofagasta had higher late
fetal and infant mortality rates than Valparaiso, whereas after 1970 the rates
declined to comparable levels between the
two towns. It appears that the increase in
arsenic in the water supply served to delay
the improvement in fetal and infant health
until the arsenic-removal plant was installed
(Figures 3-5).

The results of this study should be considered within the context of limitations in
the study design and in the type of data
obtained. In general, ecologic studies are susceptible to biases that pertain to the lack of
individual data on exposure, outcomes, and
confounders. These biases, known as the
ecologic fallacy, have been discussed in detail
elsewhere (61). In this study, although exposure was measured at the group level, public
water was consumed by most residents in
each of the communities, the water supply
came from one main source at each location,
and we adjusted for community differences
in the model. However, we lacked data on
individual-level confounders, and therefore
we cannot definitely exclude the possibility
of an ecologic bias. Nevertheless, the distinct
temporal pattern of infant mortality rates in
Antofagasta as compared to Valparaiso
argues against this bias. That is, residual confounding from factors not available would
have to closely relate to the timing of the
high arsenic exposure documented in
Antofagasta. The change in the arsenic level

of the water supply was an indisputable
event, and no other environmental pollutant
has been described to account for the many
documented health effects experienced by
the population of Antofagasta during the
study time period (8,20,44,46,62-65).
Thus, it would not be surprising if these
reproductive events were also due to the consumption of water with high arsenic.
The underascertainment of both birth
and death registrations is typically a potential concern of studies of this design. With
regard to birth registration, there is evidence
of underascertainment, which has substantially declined over time. In Chile, children
whose births are not registered by March of
the year after they were born are categorized
separately. A study of birth registrations
from 1955-1988 showed variations ranging
from 11.4 to 4.2% in late birth registrations
(66). We also observed variations between
regions; Antofagasta and Valparaiso were
consistently among those with the lowest
late registration rates. The increase in births
that occur in hospitals (42.3% in 1953 vs.

Table 4. Poisson regression analysis for secular trends in fetal, neonatal, and postneonatal mortality by
arsenic exposure, location, and calendar time.
Fetal mortality
Neonatal mortality
Postneonatal mortality
RR
Variable
Cl
RR
Cl
RR
Cl
Arsenic exposure
No
1.0
1.0
1.0
(Referent)
(Referent)
(Referent)
1.7
1.4-1.7
Yes
1.5-1.9
1.5
1.3
1.2-1.3
Location
1.0
1.0
1.0
Valparaiso
(Referent)
(Referent)
(Referent)
1.1
1.1-1.2
1.1
1.0-1.1
1.5
1.4-1.6
Antofagasta
Calendar time
2.1
1.8-2.3
1.7
1.6-1.9
3.0
2.8-3.3
1950-1953
1.4
2.7
1954-1957
1.2-1.6
1.5
1.4-1.6
2.5-2.9
1.2
1.1-1.4
1.2
2.8
2.6-3.0
1958-1961
1.1-1.3
2.2
1.4
1.2-1.6
1.3
1.1-1.4
2.1-2.4
1962-1965
1.1
1.2
1.1-1.4
1.0-1.2
1.8
1.7-2.0
1966-1969
1.1
1.1
1.0-1.2
1.2
1.1-1.4
1.0-1.2
1970-1973
1.0
1.0
1.0
1974-1977
(Referent)
(Referent)
(Referent)
0.7
0.6-0.8
0.5
0.6
0.5-0.7
0.5-0.6
1978-1981
0.4
0.4-0.5
0.5
0.5-0.6
0.4
0.4-0.5
1982-1 985
0.4-0.5
0.3
0.5-0.7
0.5
0.3-0.4
0.6
1986-1989
0.2-0.3
0.4
0.3-0.4
0.3
0.4-0.6
1990-1993
0.5
0.2
0.4
0.2-0.3
0.4-0.6
0.3-0.4
0.5
1994-1 996
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99.7% in 1994) and births assisted by medical professionals (57.5% in 1953 vs. 100%
in 1994) also impacts the completeness of
birth registration. Regional statistics show
that Antofagasta and Valparaiso were two of
the four provinces with the highest percentage of physician-assisted births in 1953,
compared to the rest of Chile (6/).
Death registration is also characterized
by omissions, especially for newborns that
died in the first hours or days after birth. A
study conducted in Santiago in 1968-1969
showed that over one-half of the hospitalborn babies who died were not registered
(68). Another study in Santiago found that
13% of the deaths of children younger than
5 years of age (69) were not registered, and
most of this underregistration occurred for
deaths in the neonatal period. In Chile, the
certification of infant deaths by a physician
increased from 55% in 1952 (68) to 96% in
1994 (58). The omissions in death reporting
and the late birth registrations affect mortality rates, which will be biased up or down
depending on whether birth or death omissions were higher. However, given the much
greater number of births than deaths, underreporting of deaths will have a much greater
effect on the rates. In a study of 1976-1978
mortality by region, medical certification
was used as an indirect measure of relative
accuracy in the reporting of death (69,70).
Antofagasta and Valparaiso were among the
few provinces with < 5% of deaths lacking
medical certificates (69,70). There is no evidence that underreporting was significantly
different between the two study areas, but
we did not find any published report with
specific comparisons of fetal and infant mortality omissions by geographical locations
across time.
In addition to the ecologic nature of the
study and the potential effects of underascertainment of births or deaths, our analysis did
not include other contaminants. For example, differences in exposures to pesticides or
other metals could have an effect on infant
mortality. Although we do not have specific
information on pesticides, their use has been
historically very limited in the Antofagasta
region because it is a desert area with only
local small-scale agriculture. On the contrary,
the Valparaiso region is one of the most productive agricultural areas of the country. If
pesticide exposure increased infant mortality,
it would tend to increase the rates in
Valparaiso so that the true RRs due to arsenic
could be higher than those observed. On the
other hand, the Antofagasta region has a history of mining and smelting that could have
the opposite effect. However, most exposed
activities are not close to the city of
Antofagasta. Most importantly, it is unlikely
that the clear sharp increase in arsenic water
672

levels, followed by the decrease 12 years later
with the installation of the arsenic-removal
plant, would be accompanied by another
contaminant with a similar temporal pattern.

Summary and
Recommendations
Although there is suggestive evidence for
arsenic-related human developmental toxicity, the existing literature falls short of establishing a clear causal association between
environmental arsenic exposure and reproductive health effects. The findings presented
in this paper, albeit not definitive, support a
role for arsenic in the increased late fetal and
infant mortality observed in Antofagasta.
Further studies are needed to investigate the
broad range of reproductive and developmental effects, ranging from low birth weight
to infant death, that may be causally related
to arsenic in environmentally exposed populations around the world. The study designs
of these investigations should consider using
defined populations, with individual-level
data and well-delineated methods of exposure
assessment for arsenic and collection of data
for potential confounding variables.
Results from the present study, the
prospective cohort study under way in Chile
by our group, and additional studies of this
nature are important in the context of the
ongoing review of the arsenic drinking
water standard.
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